POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ('IGC Pharma' or the 'Company') announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

The obesity market was a dominating force in 2024, with GLP-1 medications from Novo Nordisk and Eli Lilly becoming some of ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

China’s Innovent Biologics today announced a collaboration and exclusive license agreement with Swiss pharma giant Roche to ...

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

Full mergers and acquisitions in the pharmaceutical and biotechnology in 2024 fluctuated throughout the year with hardly any in some months and a significant number in other. But one thing was clear – ...

We’ve seen several high-profile transactions in life sciences, resulting in big exits for investors in the private and public ...

Widespread H5N1 infection in dairy cows led California to declare a bird flu emergency in December. This virus is different from the one that caused the fatality, and is classified as Influenza A H5N1 ...

Shares of hVIVO plc (LON:HVO – Get Free Report) dropped 6.8% during trading on Friday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares ...